BIBS 39
CAS: 133085-33-3
Ref. 3D-IFA08533
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
- 4'-((2-Butyl-6-(((cyclohexylamino)carbonyl)amino)-1H-benzimidazo-1-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
- 4'-((2-n-Butyl-6-cyclohexylaminocarbonylaminobenzimidazole-1-yl)methyl)biphenyl-2-carboxylic acid
- (1,1'-Biphenyl)-2-carboxylic acid, 4'-((2-butyl-6-(((cyclohexylamino)carbonyl)amino)-1H-benzimidazo-1-yl)methyl)-
- 4'-({2-butyl-6-[(cyclohexylcarbamoyl)amino]-1H-benzimidazol-1-yl}methyl)biphenyl-2-carboxylic acid
BIBS 39 is a potent and selective non-peptide angiotensin II type 1 receptor antagonist. It blocks the binding of angiotensin II to its receptors, which inhibits the activation of the angiotensin system. This prevents the production of vasoconstrictive peptides, such as angiotensin II, and reduces blood pressure. BIBS 39 has been shown to be effective against ventricular dysfunction in rats with cirrhosis and congestive heart failure. BIBS 39 also has an antihypertensive activity in Sprague-Dawley rats that may be due to its inhibition of oxidative stress.
Chemical properties
Technical inquiry about: 3D-IFA08533 BIBS 39
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
